# Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization

> **NCT02880605** · — · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 11235 (actual)

## Conditions studied

- Appropriate Use Criteria
- Coronary Revascularization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02880605
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 11235 (ACTUAL)
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880605

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880605, "Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02880605. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*